The authors provide a concise review of recent developments in the field of viral hepatitis, based on publications between December 2006 and November 2007. Current Opinion in Gastroenterology
This review considers antiangiogenic therapy for colorectal, gastric, hepatocellular and pancreatic cancer. The mechanism of action and application of bevacizumab are emphasized, but other potential antiangiogenic targets and therapies are also discussed. Nature Clinical Practice Gastroenterology & Hepatology
Fatigue, a significant problem in patients with non-alcoholic fatty liver disease (NAFLD), cannot be attributed merely to weight problems, according to a report in the June issue of Gut. Reuters Health Information
A literature review suggests that many clinicians are unaware of a rare, but potentially fatal gastrointestinal hypomotility that can occur with clozapine use, according to a report by investigators in New Zealand. Reuters Health Information
Abdominal bloating and visible distension are common and have similar risk factors, according to findings from a population-based study published in the June issue of Gut. Reuters Health Information
Angiographic embolization for gastroduodenal hemorrhage can be achieved technically in most patients, but in-hospital rebleeding occurs in almost half of cases, researchers report in the May issue of the Archives of Surgery. Reuters Health Information
Small intestinal bacterial overgrowth (SIBO) is common and contributes to symptoms in patients with systemic sclerosis, according to a report in the May issue of the American Journal of Gastroenterology. Reuters Health Information
While much new information on the pathogenesis and natural history of NAFLD is available, an effective therapy remains to be established. Current Opinion in Gastroenterology
Chemoimmunotherapy with 5-fluorouracil, adriamycin, and poly A:U shows a survival advantage over 5-fluorouracil and adriamycin alone. Annals of Oncology
